Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cooper, J. D
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cooper, J. D
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Use of aprotinin in lung transplantation

Joel D Cooper

Thoracic Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Missouri

Although the use of aprotinin has been well documented for cardiac surgical procedures, its use in lung transplantation has received less attention. Herein is the experience at Washington University with aprotinin in patients undergoing lung transplantation (most with cystic fibrosis). In these patients, bleeding from the chest wall is a major problem due to the dense adhesions from chronic infection. Aprotinin has a dramatic effect in reducing bleeding.

Perfusion, Vol. 8, No. 1 suppl, 43-46 (1993)
DOI: 10.1177/026765919300800107
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?